EMV EMVision Medical Devices Ltd
Healthcare · Medical Devices
· website
$1.56
52wk 1.47 – 1.96
Overall
55.4
Value
62.5
Growth
100.0
Health
68.9
Quality
0.0
Momentum
23.6
Dividend
—
Price
About EMVision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Price analytics
Returns
| 1 day | -0.6% |
| 1 week | -10.3% |
| 1 month | -12.4% |
| 3 months | 0.6% |
| 6 months | 0.6% |
| 1 year | -15.4% |
| 3 years | -2.5% |
Risk
| Volatility (1y ann.) | 41.2% |
| Beta vs ASX 200 | 0.50 |
| Sharpe (1y) | -0.30 |
| VaR 95% (1-day) | -3.8% |
| Max drawdown (1y) | -24.3% |
| Off 1-year high | -20.2% |
Technicals
| RSI(14) | 38 |
| vs 50DMA | -8.4% |
| vs 200DMA | -8.1% |
| Trend | Golden cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
62.5
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
0
Price / Sales
0
Growth
100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
68.9
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
99
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
23.6
6-month return vs ASX 200
38
Price vs 200-day average
23
Price vs 50-day average
8
Position in 52-week range
18
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$145.01M
P/E (trailing)
—
P/E (forward)
-12.00
EPS (trailing)
-0.09
Dividend yield
—
Payout ratio
0.0%
Beta
1.06
EV / EBITDA
-15.51
Price / Book
9.18
ROE
-66.4%
Operating margin
-100.8%
Net margin
-99.5%
Total cash
$17.10M
Total debt
$3.41M
Current ratio
5.53
Debt / Equity
0.22
Free cash flow
$-3.64M
Avg volume
33,489
Latest annual results
(FY ending 30 Jun 2026)
- Revenue—
- Gross profit—
- Operating income-$16.93M
- Net income-$8.32M
- Diluted EPS—
- Free cash flow-$6.37M
- Net debt-$13.70M